Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-06-09

Clinical Trial Update: Prevalence of Secondary Cardiac Damage in Rheumatic Fever Patients and Penicillin Secondary Prophylaxis

View source ↗

Summary

The update examines the prevalence of secondary cardiac damage among rheumatic fever patients and the use of penicillin for secondary prophylaxis. The current t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Penicillin (penicillin)

Snippet

Sponsor: Assuta Hospital Systems | Conditions: Secondary Cardiac Damage in Rheumatic Fever | Status: UNKNOWN